All Episodes
Diagnosing Health Care Podcast — 81 episodes
DOJ's Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams
The Down-Low on Data for Value-Based Enterprises and Their Participating Providers
42 CFR Part 2 Final Rule: What's Changing and What Do You Need to Know?
Current Tailwinds in Women's Health - What Do They Mean for Your Business?
Can Food Really Be Medicine? Transforming Health Care One Bite at a Time
Breaking Down the Shifting Vaccine Policy Landscape
Executive Actions Impact Federally Funded Research: What Institutions Should Do Now
Criminal Health Care Fraud Enforcement: Projections for 2025 and Beyond
2025 Outlook: The Department of Health and Human Services Under the Second Trump Administration
Health Policy Update: Impact of the 2024 U.S. Elections
Advancements of Artificial Intelligence in Health Care – One Year After White House Executive Order
Workplace Violence in Health Care: Dissecting the Legal Landscape and Implications for Employers
Navigating the Labyrinth of Private Equity Investments in Health Care
The DEA Is Knocking at Your Door . . . Are You Prepared?
The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
Down Goes Chevron: A 40-Year Precedent Overturned by the Supreme Court
Unveiling Gender-Affirming Care: Why It Matters and What's at Stake
Key Changes in Finalized Antitrust Merger Guidelines
Health Equity: Behind the Buzzwords
Telehealth Post-Public Health Emergency: What to Expect in 2024
Antitrust Updates: Changes Affecting Merger Review and Enforcement in 2024 and Beyond
Dietary Supplements: Navigating the Regulatory Maze
Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
Inflation Reduction Act's Drug Price Negotiation Provisions – What Now?
Post-Dobbs: One Year Later
Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
The Legal Battle Over Mifepristone
Inflation Reduction Act's Drug Price Negotiation Provisions – What's Next?
Direct Access Laboratory Testing: Physician Orders and Specimen Collection
Legal and Regulatory Landscape for Psychedelics as Therapies
2023 Deal Cycle: Considerations for Transactions in Uncertain Economic Times
The End of the Public Health Emergency – What's to Come?
Direct Access Laboratory Testing: Reimbursement & Compliance
Direct Access Laboratory Testing: Navigating the Regulatory Landscape
Unpacking FDA's Final Clinical Decision Support Guidance
The PACE Program: What Changes May Be Coming Soon?
Post-Dobbs: Considerations for Clinical Trials and Research
2023 Health Policy Outlook
Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
Post-Dobbs: Navigating the Fast-Changing and Uncertain Legal Landscape
Health Care's Past, Present, and Future
Hot Areas in COVID-19 Enforcement, Testing, and Funding
Interoperability: Information Blocking Claims and Enforcement
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
Interoperability: Health Care's Next Disruptor Is openEHR
Interoperability: A New Vision Through openEHR
OSHA's Permanent COVID-19 Standard and Enforcement Blitz
Entrepreneurship in Biotech: Growing Your Business
DOJ Goes After Civil Cyber-Fraud
Interoperability: The Role of Health Information Exchanges
Interoperability: The Provider Perspective
Chevron Deference: Is It Time for Change?
No Surprises Act: New Rules and Guidance for Stakeholders (Part 2)
No Surprises Act: New Rules and Guidance for Stakeholders (Part 1)
How Will Biden's Executive Order Impact Future Hospital Mergers?
What Is the Future of the Acute Care Hospital Industry?
Is the Dietary Supplement Regulatory Framework Working?
No Surprises Act: Considerations for Plans and Providers
How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture?
What's New for Insurers in Mental Health Parity Compliance
Federal and State Cannabis Rules Are Moving in Different Directions
Are Vaccine Passports the Key to Reopening?
Whistleblowing, Retaliation Risks Are On the Rise for Health Care Employers
CMS and OIG Final Rules for Innovating Your Value-Based Payment Program
American Rescue Plan Delivers New Stimulus Funding
President Biden's Use of the Defense Production Act
COVID-19 Vaccines: The Ethical and Legal Challenges to Immunization
Congressional Health Care Legislative Agenda
Private Equity Investment in Risk-Bearing Provider Organizations
The Biden Administration's First 100 Days
Forecast for Telehealth Fraud and Abuse Risk in 2021
Privacy Concerns When Contact Tracing in the Health Care Workplace
SCOTUS Watch: The ACA and Key Health Law Areas Justice Barrett Could Impact
On the Ballot 2020: Health Care Policy Outlook
Key Considerations for Reshoring U.S. Drug Manufacturing
Product Launching in the Era of COVID-19
Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking
Fraud and Abuse Enforcement Priorities in the Wake of COVID-19
The Impact of Revenue and Budget Shortfalls in Light of Coronavirus
Telehealth Flexibility
Welcome to the Diagnosing Health Care Podcast